New Zealand markets open in 7 hours 44 minutes

Regulus Therapeutics Inc (7RG0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.0800+0.0200 (+0.97%)
As of 12:16PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
10,006
Operating expenses
Research development
22,267
21,152
18,410
17,794
15,347
Selling general and administrative
10,299
9,957
9,829
10,022
8,814
Total operating expenses
32,566
31,109
28,239
27,816
24,161
Operating income or loss
-32,566
-31,109
-28,239
-27,816
-14,155
Interest expense
500
604
688
855
1,808
Income before tax
-31,366
-30,036
-28,322
-27,807
-15,730
Income tax expense
-
1
1
1
0
Income from continuing operations
-31,367
-30,037
-28,323
-27,808
-15,730
Net income
-31,367
-30,037
-28,323
-27,808
-15,730
Net income available to common shareholders
-31,367
-30,037
-28,323
-27,808
-15,730
Basic EPS
-1.59
-1.58
-1.86
-3.24
-4.50
Diluted EPS
-1.59
-1.58
-1.86
-3.24
-4.50
Basic average shares
18,116
18,960
15,260
8,570
3,498
Diluted average shares
18,116
18,960
15,260
8,570
3,498